Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICUNASDAQ:IRIXNASDAQ:LYRANASDAQ:MHUA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICUSeaStar Medical$0.42+17.6%$1.16$0.31▼$13.85$4.03M-0.891.46 million shs276.77 million shsIRIXIRIDEX$0.94-0.6%$1.04$0.78▼$2.41$15.92M0.6150,779 shs41,582 shsLYRALyra Therapeutics$12.30-4.4%$8.80$3.81▼$37.50$17.04M-0.01188,561 shs62,746 shsMHUAMeihua International Medical Technologies$0.42+0.4%$0.38$0.25▼$1.47$13.19M0.85688,452 shs79,259 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICUSeaStar Medical+17.63%-56.84%-66.43%-80.77%-93.35%IRIXIRIDEX-0.57%-3.42%-3.79%+6.78%-55.94%LYRALyra Therapeutics-4.35%+15.17%+167.97%+61.10%-4.65%MHUAMeihua International Medical Technologies+0.39%+1.24%+8.92%+18.44%-52.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationICUSeaStar Medical0.7222 of 5 stars0.03.00.00.02.81.70.0IRIXIRIDEX0.3156 of 5 stars0.03.00.00.00.81.70.0LYRALyra Therapeutics2.3553 of 5 stars3.24.00.00.01.11.70.6MHUAMeihua International Medical Technologies0.8116 of 5 stars0.05.00.00.00.01.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICUSeaStar Medical 0.00N/AN/AN/AIRIXIRIDEX 0.00N/AN/AN/ALYRALyra Therapeutics 2.33Hold$100.00713.01% UpsideMHUAMeihua International Medical Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICUSeaStar Medical$140K33.84N/AN/A($0.34) per share-1.24IRIXIRIDEX$48.67M0.33N/AN/A$0.13 per share7.25LYRALyra Therapeutics$1.53M10.69N/AN/A$8.86 per share1.39MHUAMeihua International Medical Technologies$96.90M0.14$0.46 per share0.91$6.34 per share0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICUSeaStar Medical-$24.83M-$3.47N/A∞N/AN/AN/A-313.28%8/12/2025 (Estimated)IRIXIRIDEX-$8.91M-$0.43N/A∞N/A-14.61%-290.57%-22.86%8/6/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)MHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/ALatest ICU, IRIX, LYRA, and MHUA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025ICUSeaStar Medical-$0.52-$0.44+$0.08-$0.44$0.15 million$0.29 million5/13/2025Q1 2025IRIXIRIDEX-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 million3/27/2025Q4 2024ICUSeaStar Medical-$0.89-$0.90-$0.01-$0.90$0.15 million$0.07 million3/27/2025Q4 2024IRIXIRIDEX-$0.05-$0.05N/A-$0.05$12.80 million$12.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICUSeaStar MedicalN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICUSeaStar MedicalN/A0.960.96IRIXIRIDEX4.281.951.27LYRALyra TherapeuticsN/A2.962.96MHUAMeihua International Medical TechnologiesN/A5.265.21Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICUSeaStar Medical1.69%IRIXIRIDEX20.10%LYRALyra Therapeutics95.62%MHUAMeihua International Medical Technologies1.17%Insider OwnershipCompanyInsider OwnershipICUSeaStar Medical1.30%IRIXIRIDEX7.40%LYRALyra Therapeutics3.25%MHUAMeihua International Medical Technologies66.56%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICUSeaStar Medical211.20 million11.06 millionNot OptionableIRIXIRIDEX12016.79 million15.55 millionOptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableICU, IRIX, LYRA, and MHUA HeadlinesRecent News About These CompaniesMeihua International Gains Nasdaq Capital Market Approval Amid Compliance EffortsJune 6, 2025 | tipranks.comMeihua International Medical Technologies Full Year 2024 Earnings: EPS: US$0.40 (vs US$0.49 in FY 2023)April 27, 2025 | finance.yahoo.comMeihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year ResultsApril 25, 2025 | prnewswire.comMeihua International Halts Convertible Note Sales, Amends Securities AgreementJanuary 3, 2025 | tipranks.comMeihua International Medical Technologies (NASDAQ:MHUA) Is Reinvesting At Lower Rates Of ReturnDecember 23, 2024 | uk.finance.yahoo.comRemote medical interpreting is a double-edged sword in healthcare communication, researchers findNovember 6, 2024 | sciencedaily.comSDigital Medical and Artificial Intelligence Innovation Forum Held in BeijingOctober 31, 2024 | markets.businessinsider.comGlobal medical technology firm shifts some of its California manufacturing to MexicoOctober 22, 2024 | msn.comMeihua Intl Medical Techs (NASDAQ:MHUA) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comMeihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price RequirementOctober 7, 2024 | prnewswire.comMeihua Intl Medical Techs (NASDAQ:MHUA) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comMeihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)September 25, 2024 | finance.yahoo.comMeihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial ResultsSeptember 20, 2024 | prnewswire.comFrost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.September 18, 2024 | digitimes.comDMIT xPRO Launches the Medical Technology Program for Global Leaders in Collaboration with EmeritusSeptember 18, 2024 | tmcnet.comICMR signs agreements with Industry, Academic Partners to Advance First-in-Human Phase 1 Clinical TrialsSeptember 15, 2024 | malaysiasun.comMMeihua International Medical Technologies Co., Ltd. to Present at LIVE!August 26, 2024 | prnewswire.comEpica International Inc. Partners With M.A.R.C. Institute, Pioneering Medical EducationAugust 15, 2024 | joplinglobe.comJMeihua International Medical Technologies Co Ltd (NASDAQ:MHUA) Stock Price Slipped -9.80% to $0.92August 2, 2024 | bovnews.comBMeihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted LobectomyJuly 31, 2024 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Industrials Stocks Standing Out for Growth and Analyst OptimismBy Nathan Reiff | June 4, 2025View 3 Industrials Stocks Standing Out for Growth and Analyst OptimismWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]ICU, IRIX, LYRA, and MHUA Company DescriptionsSeaStar Medical NASDAQ:ICU$0.42 +0.06 (+17.63%) Closing price 06/25/2025 04:00 PM EasternExtended Trading$0.44 +0.01 (+2.84%) As of 06/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.IRIDEX NASDAQ:IRIX$0.94 -0.01 (-0.57%) Closing price 06/25/2025 04:00 PM EasternExtended Trading$0.97 +0.03 (+2.77%) As of 06/25/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.Lyra Therapeutics NASDAQ:LYRA$12.30 -0.56 (-4.35%) Closing price 06/25/2025 04:00 PM EasternExtended Trading$12.00 -0.30 (-2.40%) As of 06/25/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Meihua International Medical Technologies NASDAQ:MHUA$0.42 +0.00 (+0.39%) Closing price 06/25/2025 03:58 PM EasternExtended Trading$0.42 +0.00 (+0.96%) As of 06/25/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside AeroVironment Will Hit New Highs This Year: Bull Flag Confirmed Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides Palantir Stock Hits ATH, But Can the Rally Hold Without Volume? Costco at a Crossroads: Is the Next Move Higher or Lower? AST SpaceMobile's Signal Strengthens as Stock Nears Orbit Oracle Stock Boils Higher, $300 Price Target in Sight 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
